SCHEMBL108917

SCHEMBL108917

CC(C)C(O)CCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.50
TSHR P16473 2/20 0.50
MEN1 O00255 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HPGD P15428 1/20 0.47
SLC6A2 P23975 3/20 0.46
SLC6A3 Q01959 3/20 0.46
SLC6A4 P31645 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
KCNH2 Q12809 2/20 0.46
OPRK1 P41145 2/20 0.46
LMNA P02545 1/20 0.45
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
ADRA2B P18089 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14088168 0.88 MMP12 (0.56) HTTCYP2D6KCNH2LMNACYP1A2
SCHEMBL105518 0.87 TSHR (0.50) TRPA1TSHRMEN1HTTKMT2A
SCHEMBL7268763 0.86 TDP1 (0.52) TSHRSMN1; SMN2HPGDSLC6A2SLC6A3
SCHEMBL30146557 0.86 TDP1 (0.52) TSHRSMN1; SMN2HPGDSLC6A2SLC6A3
SCHEMBL30146580 0.86 TDP1 (0.52) TSHRSMN1; SMN2HPGDSLC6A2SLC6A3
SCHEMBL14975377 0.86 TRPA1 (0.50) TRPA1KMT2AHPGD
Hydrochloric Acid SCHEMBL9848355 0.84 MAOB (0.50) TSHRHPGDSLC6A2SLC6A3SLC6A4
SCHEMBL14159706 0.83 ANPEP (0.50) TRPA1TSHRMEN1HTTKMT2A
SCHEMBL109557 0.82 TSHR (0.53) TSHRMEN1HTTKMT2ASMN1; SMN2
SCHEMBL2942774 0.82 TSHR (0.53) TSHRMEN1HTTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11603506-B2 Product comprising a plastic container and a substance composition SYMRISE AG (DE) 2023-03-14 US claimed
US-20190225396-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION SYMRISE AG (DE) 2019-07-25 US claimed
EP-3507352-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION Symrise AG (DE) 2019-07-10 EP claimed
WO-2018041354-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION SYMRISE AG (DE) 2018-03-08 WO claimed
WO-2014110035-A1 ODOR SUPPRESSION OF VOLATILE ORGANIC ANALGESIC COMPOUNDS AND METHOD OF USE CHATTEM, INC. (US) 2014-07-17 WO claimed
US-8697043-B1 Odor suppression of volatile organic analgesic compounds and method of use CHATTEM, INC. (US) 2014-04-15 US claimed
EP-2463374-A2 Isolated alcohol dehydrogenase enzymes and uses thereof Bio Architecture Lab, Inc. (US) 2012-06-13 EP claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US claimed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
EP-3230463-B2 RAPID PRETREATMENT APALTA PATENTS OUE (EE) 2025-07-16 EP disclosed
US-20240425893-A1 RAPID PRETREATMENT Apalta Patents OÜ (EE) 2024-12-26 US disclosed
US-12054761-B2 Rapid pretreatment Apalta Patents OÜ (EE) 2024-08-06 US disclosed
US-11821047-B2 High pressure zone formation for pretreatment Apalta Patent OÜ (EE) 2023-11-21 US disclosed
WO-1998047995-A1 ORTHOCARBONATE PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO disclosed
US-5492934-A ADMINISTERING 3-METHYL-5-PHENYL-3-PENTANOL HIRSCH ALAN R (US) 1996-02-20 US disclosed
US-5380765-A P-ethylphenol HIRSCH ALAN R (US) 1995-01-10 US disclosed
US-5236780-A Substrate, surface treating layer, pressure rupturing microcapsules with perfume BROTHER KOGYO KABUSHIKI KAISHA (JP) 1993-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090139134-A1 BIOFUEL PRODUCTION MGAM, DCXR, MANBA TRPA1 3765/4885TSHR 3426/4885MEN1 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.